Breast Cancer Beliefs and Behaviors at the San Francisco General Hospital.

Breast J

Department of Surgery,AIDS/Oncology Program, and San Francisco Injury Center, University of California San Francisco/San Francisco General Hospital, San Francisco, California.

Published: January 2000

This study compared an ethnically mixed population of lower socioeconomic status women regarding their breast cancer beliefs, surgical decision making, sources of information, reactions to the diagnosis, and use of support groups. A 20-item oral survey was administered to a convenience sample recruited at the San Francisco General Hospital breast clinic during 1997. Data were analyzed by chi-square analysis with stratification according to age, ethnicity, education, and language. Corrections were made for small frequencies. P values of less than 0.05 were considered significant. The mean age (n = 30) was 56 years (range 39-72 years). Ten participants were African American, 7 Caucasian, 6 Filipino, 4 Chinese, and 3 Latina. Education averaged 12 years. Ten were non-English speakers. Breast cancer beliefs varied by ethnicity, age, and education. Surgical decision making showed that less formally educated women tended to include the doctor in decision making more often. Sources of information varied by English language capacity. Reactions to the diagnosis and use of support groups showed no difference among the categories. Some results of this study corroborate reports of breast cancer beliefs and decision-making styles published in the literature. Differences noted in the study may be explained in part by socioeconomic and ethnic differences between our population and those commonly sampled in the literature. These results suggest the need for further research in multiethnic and low-income populations with breast cancer. They also suggest some important implications for understanding community educational needs.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1524-4741.2000.t01-1-98087.xDOI Listing

Publication Analysis

Top Keywords

breast cancer
20
cancer beliefs
16
decision making
12
san francisco
8
francisco general
8
general hospital
8
surgical decision
8
making sources
8
reactions diagnosis
8
diagnosis support
8

Similar Publications

Gene Polymorphisms in Greek Primary Breast Cancer Patients.

Front Biosci (Schol Ed)

December 2024

Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.

Background: Breast cancer is a heterogeneous disease with distinct clinical subtypes, categorized by hormone receptor status, which exhibits different prognoses and requires personalized treatment approaches. These subtypes included luminal A and luminal B, which have different prognoses. Breast cancer development and progression involve many factors, including interferon-gamma ().

View Article and Find Full Text PDF

Objective: The current study aimed to develop an experimental approach for the direct co-culture of three-dimensional breast cancer cells using single-cell RNA sequencing (scRNA-seq).

Methods: The following four cell culture groups were established in the Matrigel matrix: the untreated Michigan Cancer Foundation (MCF)-7 cell culture group, the MCF-7 cell culture plus cisplatin group, the untreated co-culture group, and the cell co-culture plus cisplatin group. For cell co-culture, MCF-7 cells, human mammary fibroblasts, and human umbilical vein endothelial cells were mixed at a ratio of 1:1:1.

View Article and Find Full Text PDF

Clinical Relevance and Drug Modulation of PPAR Signaling Pathway in Triple-Negative Breast Cancer: A Comprehensive Analysis.

PPAR Res

December 2024

Department of Laboratory Medicine, The Sixth School of Clinical Medicine, The Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, China.

Triple-negative breast cancer (TNBC) is highly heterogeneous and poses a significant medical challenge due to limited treatment options and poor outcomes. Peroxisome proliferator-activated receptors (PPARs) play a crucial role in regulating metabolism and cell fate. While the association between PPAR signal and human cancers has been a topic of concern, its specific relationship with TNBC remains unclear.

View Article and Find Full Text PDF

Previous studies have demonstrated that many healthcare workers in low- and middle-income countries (LMICs) lack the appropriate training and knowledge to recognize and diagnose breast cancer at an early stage. As a result, women in LMICs are frequently diagnosed with late-stage breast cancer (Stage III/IV) with a poor prognosis. We hosted a 1-day breast cancer educational conference directed towards healthcare workers in Honduras.

View Article and Find Full Text PDF

Deep learning identification of novel autophagic protein-protein interactions and experimental validation of Beclin 2-Ubiquilin 1 axis in triple-negative breast cancer.

Oncol Res

December 2024

Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.

Background: Triple-negative breast cancer (TNBC), characterized by its lack of traditional hormone receptors and HER2, presents a significant challenge in oncology due to its poor response to conventional therapies. Autophagy is an important process for maintaining cellular homeostasis, and there are currently autophagy biomarkers that play an effective role in the clinical treatment of tumors. In contrast to targeting protein activity, intervention with protein-protein interaction (PPI) can avoid unrelated crosstalk and regulate the autophagy process with minimal interference pathways.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!